Subscribe

Iofina plc (IOF.L)

GBp58.00 +2.50 (+4.50%)
GB LSE Basic Materials Chemicals - Specialty
Address 48 Chancery Lane WC2A 1JF
London, GB
CEO Thomas Matthew Becker
Website iofina.com
IPO 2008-05-09
ISIN GB00B2QL5C79

Explore sections of this company profile

Also trades on London Stock Exchange · IOF.L (GBp) Other OTC · IOFNF (USD)
Description

Iofina plc, together with its subsidiaries, explores for, develops, and produces iodine and halogen-based specialty chemical derivatives from oil and gas operations in North America, Asia, South America, Europe, and internationally. The company offers iodides, chlorides, and fluorides; and iodine used for animal care and health, biocides and catalysts, disinfectants, fungicide, specialty intermediates, mineral separators, thyroid health, wound healing, diagnostic imaging, iofina logo gray sun 5, preservatives and sanitizers, semiconductor etchant gas, soil fumigants, fine halogen chemicals, electronic specialty gases, and heat stabilizers applications. The company markets its products in electronics/semiconductor, pharmaceutical, food and beverage, personal care, paints and coatings, dairy, chemical intermediates, gemological, fish and wildlife, nylon, x-ray contrast media industries. It serves animal nutrition, biocidal paints and coatings, disinfectants, x-ray contrast media, pharmaceuticals, electronics, perovskites for solar, optical polarizing films, industrial, oil and gas industries. The company sells its products under the IOflo and IOprill brand names. Iofina plc was incorporated in 2005 and is based in London, the United Kingdom.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
GBp58.00 +2.50 (+4.50%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
782.1K
Beta
0.87
Float Shares
110.66M
Free Float %
57.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-1.03% +3.23% +41.18% +83.91% +134.15% +82.86% +104.26% +33.33% +300.00% +183.81% -30.57%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
58.00
DCF (Unlevered) 7.18 -87.6%
DCF (Levered) 36.95 -36.3%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 1 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
6.62
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
A+
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Chemicals - Specialty: +4.7%
    +24.7% ★ Q4'25: +45.8% (vs Q4'23)
  • ✓
    EPS growth Chemicals - Specialty: +13.2%
    +172.7% ★ Q4'25: +79.1% (vs Q4'23)
  • ✓
    FCF margin FCF growth · Chemicals - Specialty: +44.1%
    +4.3% Q4'25: +16.7% (vs Q4'23)
  • ✗
    EBIT margin Chemicals - Specialty: +8.8%
    +13.1% ★ Q4'25: +18.5% (vs Q4'23)
  • ✗
    ROIC Chemicals - Specialty: +5.6%
    +13.1% ★ Q4'25: +41.7% (vs Q4'23)
  • ✗
    Share dilution Chemicals - Specialty: +0.1%
    +0.4% Q4'25: 0.0% (vs Q4'23)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    0.55× ★ Q4'25: 0.19× (vs Q4'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.85) × ERP
WACC = 95% × Ke + 5% × Kd (4.8%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 8.43 Current price: 58.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2012
actual 		Dec 2013
actual 		Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
1 Rev. Ana.
1 EPS Ana. 		Dec 2027
1 Rev. Ana.
1 EPS Ana. 		Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
18.64M
est: 21.67M (-14.0%)
18.93M
est: 19.51M (-3.0%)
20.33M
est: 20.68M (-1.7%)
22.49M
est: 20.76M (+8.4%)
20.83M
est: 20.67M (+0.8%)
23.96M
est: 26.37M (-9.1%)
29.25M
est: 28.54M (+2.5%)
29.69M
est: 29.65M (+0.1%)
39.04M
est: 36.62M (+6.6%)
42.20M
est: 42.89M (-1.6%)
50.04M
est: 65.45M (-23.6%)
54.47M
est: 54.50M (-0.1%)
67.91M
est: 66.44M (+2.2%)
70.53M
70.53M – 70.53M
+6.1% YoY
90.43M
90.43M – 90.43M
+28.2% YoY
121.21M
121.21M – 121.21M
+34.0% YoY
EBITDA
194.8K
est: 4.23M (-95.4%)
-1.58M
est: 180.0K (-977.7%)
491.7K
est: 192.7K (+155.2%)
367.0K
est: 4.06M (-91.0%)
-4.96M
est: 4.04M (-222.7%)
2.32M
est: 5.15M (-54.9%)
4.64M
est: 5.58M (-16.9%)
4.61M
est: 5.79M (-20.5%)
7.13M
est: 7.16M (-0.4%)
12.08M
est: 3.04M (+297.2%)
10.64M
est: 13.08M (-18.7%)
7.65M
est: 10.89M (-29.8%)
12.06M
est: 13.28M (-9.2%)
14.10M
14.10M – 14.10M
+6.1% YoY
18.08M
18.08M – 18.08M
+28.2% YoY
24.23M
24.23M – 24.23M
+34.0% YoY
EBIT
-1.18M
est: 3.25M (-136.4%)
-3.04M
est: -1.06M (-186.2%)
-1.56M
est: -1.14M (-36.8%)
-1.68M
est: 3.11M (-154.0%)
-7.04M
est: 3.10M (-327.1%)
409.6K
est: 3.95M (-89.6%)
3.03M
est: 4.28M (-29.3%)
2.93M
est: 4.44M (-34.2%)
5.49M
est: 5.49M (+0.1%)
10.36M
est: 776.0K (+1,234.6%)
8.59M
est: 10.23M (-16.0%)
5.07M
est: 8.52M (-40.5%)
8.87M
est: 10.38M (-14.6%)
11.02M
11.02M – 11.02M
+6.1% YoY
14.13M
14.13M – 14.13M
+28.2% YoY
18.94M
18.94M – 18.94M
+34.0% YoY
Net Income
-1.13M
est: -3.55M (+68.2%)
-3.74M
est: -1.02M (-268.1%)
-2.98M
est: -1.09M (-173.3%)
-3.66M
est: -6.33M (+42.1%)
-9.74M
est: -4.22M (-130.5%)
-1.14M
est: -2.65M (+56.9%)
552.4K
est: 1.70M (-67.6%)
1.28M
est: 13.63M (-90.6%)
9.19M
est: 4.49M (+104.6%)
7.87M
est: 776.0K (+913.6%)
6.56M
2.92M
est: 2.98M (-2.1%)
8.03M
est: 6.39M (+25.8%)
7.77M
7.77M – 7.77M
+21.6% YoY
12.35M
12.35M – 12.35M
+59.0% YoY
18.62M
18.62M – 18.62M
+50.8% YoY
SGA
1.21M
est: 1.97M (-38.6%)
4.95M
est: 2.93M (+68.7%)
1.64M
est: 3.14M (-47.8%)
1.70M
est: 1.89M (-10.2%)
1.03M
est: 1.88M (-45.5%)
908.2K
est: 2.40M (-62.2%)
3.82M
est: 2.60M (+47.0%)
3.69M
est: 2.70M (+36.4%)
3.79M
est: 3.34M (+13.6%)
4.36M
est: 5.00M (-12.7%)
4.87M
est: 5.52M (-11.8%)
1.83M
est: 4.60M (-60.2%)
6.16M
est: 5.61M (+9.8%)
5.95M
5.95M – 5.95M
+6.1% YoY
7.63M
7.63M – 7.63M
+28.2% YoY
10.23M
10.23M – 10.23M
+34.0% YoY
EPS
-0.01
est: -0.02 (+49.9%)
-0.03
est: -0.01 (-109.5%)
-0.02
est: -0.03 (+16.1%)
-0.03
est: -0.03 (+11.3%)
-0.08
est: -0.02 (-253.4%)
-0.01
est: -0.01 (+33.5%)
0.00
est: 0.01 (-61.0%)
0.01
est: 0.07 (-90.4%)
0.05
est: 0.02 (+108.7%)
0.04
est: 0.04 (+9.0%)
0.03
0.02
est: 0.02 (-1.1%)
0.04
est: 0.03 (+28.6%)
0.04
0.04 – 0.04
+21.6% YoY
0.06
0.06 – 0.06
+59.0% YoY
0.09
0.09 – 0.09
+50.8% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-22 A+ 4/5 4/5 5/5 5/5 3/5 3/5 4/5
2026-05-21 A+ 4/5 4/5 5/5 5/5 3/5 3/5 4/5
2026-05-20 A+ 4/5 4/5 5/5 5/5 3/5 3/5 4/5
2026-05-19 A 4/5 4/5 5/5 5/5 2/5 3/5 4/5
2026-05-18 A 4/5 4/5 5/5 5/5 2/5 3/5 4/5
2026-05-15 A 4/5 4/5 5/5 5/5 2/5 3/5 4/5
2026-05-14 A 4/5 4/5 5/5 5/5 2/5 3/5 4/5
2026-05-13 A 4/5 4/5 5/5 5/5 2/5 3/5 4/5
2026-05-12 A 4/5 4/5 5/5 5/5 2/5 3/5 4/5
2026-05-11 A 4/5 4/5 5/5 5/5 2/5 3/5 4/5
2026-05-08 A 4/5 4/5 5/5 5/5 2/5 3/5 4/5
2026-05-07 A 4/5 4/5 5/5 5/5 2/5 3/5 4/5
2026-05-06 A 4/5 4/5 5/5 5/5 2/5 3/5 4/5
2026-05-05 A 4/5 4/5 5/5 5/5 2/5 3/5 4/5
2026-05-01 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-04-30 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-04-29 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-04-28 A 4/5 5/5 4/5 5/5 2/5 3/5 4/5
2026-04-27 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-24 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-23 A- 4/5 5/5 4/5 5/5 1/5 2/5 3/5
2026-04-22 A- 4/5 5/5 4/5 5/5 1/5 2/5 3/5
2026-04-21 A- 4/5 5/5 4/5 5/5 1/5 2/5 3/5
2026-04-20 A- 4/5 5/5 4/5 5/5 1/5 2/5 3/5
2026-04-17 A- 4/5 5/5 4/5 5/5 1/5 2/5 3/5
2026-04-16 A- 4/5 5/5 4/5 5/5 1/5 2/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
20.64M
OE per share TTM
0.11
Owner's Yield
22.41%
Maintenance CapEx ratio
64.39%
Maint CapEx / Avg PPE
54.4%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
79.9K
Shares Outstanding
191.86M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Thomas Matthew Becker Chief Executive Officer, President & Executive Director 275.7K —
Malcolm Thomas Lewin Chief Financial Officer & Executive Director 202.0K male
Forest Dale Dorn Chief Operating Officer of Iofina Resources Inc — male
Kurt Jones Chief Operating Officer of Iofina Chemical Inc — male
Simon William Holden Company Secretary — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Chemicals - Specialty